Efficacy and Safety of Oral Semaglutide Versus Empagliflozin in Subjects With Type 2 Diabetes Mellitus
Public ClinicalTrials.gov record NCT02863328. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This trial is conducted globally. The aim of this trial is to investigate Efficacy and Safety of Oral Semaglutide versus Empagliflozin in Subjects with Type 2 Diabetes Mellitus.
Study identification
- NCT ID
- NCT02863328
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 822 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 9, 2016
- Primary completion
- Jul 31, 2017
- Completion
- Mar 7, 2018
- Last update posted
- Jul 19, 2022
2016 – 2018
United States locations
- U.S. sites
- 48
- U.S. states
- 21
- U.S. cities
- 42
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Tuscumbia | Alabama | 35674 | — |
| Novo Nordisk Investigational Site | Encino | California | 91436 | — |
| Novo Nordisk Investigational Site | La Mesa | California | 91942 | — |
| Novo Nordisk Investigational Site | Northridge | California | 91325 | — |
| Novo Nordisk Investigational Site | Palm Springs | California | 92262-6972 | — |
| Novo Nordisk Investigational Site | Poway | California | 92064 | — |
| Novo Nordisk Investigational Site | Riverside | California | 92506 | — |
| Novo Nordisk Investigational Site | Spring Valley | California | 91978 | — |
| Novo Nordisk Investigational Site | Bradenton | Florida | 34201 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32216 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32256 | — |
| Novo Nordisk Investigational Site | Jacksonville | Florida | 32277 | — |
| Novo Nordisk Investigational Site | Miami | Florida | 33143 | — |
| Novo Nordisk Investigational Site | Miami Lakes | Florida | 33014 | — |
| Novo Nordisk Investigational Site | Orlando | Florida | 32801 | — |
| Novo Nordisk Investigational Site | Oviedo | Florida | 32765 | — |
| Novo Nordisk Investigational Site | Atlanta | Georgia | 30328 | — |
| Novo Nordisk Investigational Site | Perry | Georgia | 31069 | — |
| Novo Nordisk Investigational Site | Meridian | Idaho | 83646 | — |
| Novo Nordisk Investigational Site | Peoria | Illinois | 61603 | — |
| Novo Nordisk Investigational Site | Evansville | Indiana | 47713 | — |
| Novo Nordisk Investigational Site | Indianapolis | Indiana | 46254 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40502 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40503 | — |
| Novo Nordisk Investigational Site | Baton Rouge | Louisiana | 70808-4124 | — |
| Novo Nordisk Investigational Site | Rockville | Maryland | 20852 | — |
| Novo Nordisk Investigational Site | Boston | Massachusetts | 02118 | — |
| Novo Nordisk Investigational Site | Buckley | Michigan | 49620 | — |
| Novo Nordisk Investigational Site | Kalamazoo | Michigan | 49009 | — |
| Novo Nordisk Investigational Site | Butte | Montana | 59701 | — |
| Novo Nordisk Investigational Site | Albany | New York | 12203 | — |
| Novo Nordisk Investigational Site | Northport | New York | 11768 | — |
| Novo Nordisk Investigational Site | Wilmington | North Carolina | 28401 | — |
| Novo Nordisk Investigational Site | Cincinnati | Ohio | 45245 | — |
| Novo Nordisk Investigational Site | Mason | Ohio | 45040-6815 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Novo Nordisk Investigational Site | Greer | South Carolina | 29651 | — |
| Novo Nordisk Investigational Site | Humboldt | Tennessee | 38343 | — |
| Novo Nordisk Investigational Site | Kingsport | Tennessee | 37660 | — |
| Novo Nordisk Investigational Site | Arlington | Texas | 76012-4637 | — |
| Novo Nordisk Investigational Site | Dallas | Texas | 75230 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77004 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77074 | — |
| Novo Nordisk Investigational Site | Katy | Texas | 77450 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78209 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78228-3419 | — |
| Novo Nordisk Investigational Site | San Antonio | Texas | 78258 | — |
| Novo Nordisk Investigational Site | Richmond | Virginia | 23219 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 58 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02863328, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 19, 2022 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02863328 live on ClinicalTrials.gov.